Relevant bibliographies by topics / N.I.H

Contents

  1. Journal articles
  2. Books
  3. Book chapters
  4. Conference papers

Academic literature on the topic 'N.I.H'

Author: Grafiati
Published: 4 June 2021
Last updated: 12 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'N.I.H.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "N.I.H"

1

&NA;. "Dynamedics awarded N.I.H. grant for blood pressure device." Journal of Cardiopulmonary Rehabilitation 9, no. 3 (March 1989): 127–28. http://dx.doi.org/10.1097/00008483-198903200-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ackerman, A. Bernard. "Critique of Definitions About Melanocytic Proliferations Formulated by an N.I.H. Panel." American Journal of Dermatopathology 14, no. 3 (June 1992): 238–44. http://dx.doi.org/10.1097/00000372-199206000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ackerman, A. Bernard. "A Critique of an N.I.H. Consensus Development Conference About “Early” Melanoma." American Journal of Dermatopathology 15, no. 1 (February 1993): 52–58. http://dx.doi.org/10.1097/00000372-199302000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ablon, Joan. "Social Dimensions of Genetic Disorders." Practicing Anthropology 14, no. 1 (January 1, 1992): 10–13. http://dx.doi.org/10.17730/praa.14.1.b800n7x364516715.

Full text
Abstract:
Each of us carries between 4-8 recessive genes for serious genetic defects, and, hence, stands a statistical chance of passing on a serious or lethal condition to each child… 12 million Americans carry true genetic disease due wholly or partly to defective genes or chromosomes…40 percent or more of all infant mortality results from genetic factors…4.8 to 5 percent of all live births have genetic defects. (U.S. Department of Health, Education, and Welfare. "What are the Facts About Genetic Disease?" National Inst. of Gen. Med. Scs., P.H.S., N.I.H. DHEW Pub. No. (NIH), 75-370, 1975.)
APA, Harvard, Vancouver, ISO, and other styles
5

Khan, Naheed Akhtar, Noor-us-Saba ., Abdus Samad ., and Ali Abbas Qazilbash . "Incidence and Antibiogram Patterns of Escherichia coli Isolated from Various Clinical Samples from Patients at N.I.H. Islamabad." Pakistan Journal of Biological Sciences 5, no. 1 (December 15, 2001): 111–13. http://dx.doi.org/10.3923/pjbs.2002.111.113.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Albas, Avelino, Regina Maria Mourão Fuches, Neuza Maria Frazatti Gallina, Rita Maria Zucatelli Mendonça, Francisco Liauw Woe Fang, and Elizabeth Juliana Ghiuro Valentini. "Termoestabilidade da vacina contra a raiva, tipo Fuenzalida & Palacios, uso humano." Revista do Instituto de Medicina Tropical de São Paulo 34, no. 1 (February 1992): 27–31. http://dx.doi.org/10.1590/s0036-46651992000100005.

Full text
Abstract:
Dez lotes de vacina contra a Raiva, tipo Fuenzalida & Palacios, líquida, uso humano, produzidos no Instituto Butantan, foram estocados às temperaturas de 45, 37, 28 e 2-8ºC. Amostras de cada lote, colhidas a intervalos de tempo que variavam com a temperatura de estocagem, tiveram sua potência (valor antigênico) determinada pelo método do N.I.H. Foram consideradas satisfatórias vacinas portadoras de um valor antigênico (VA) >0,3. Foi verificado que apenas um dos lotes apresentou VA inferior ao mínimo requerido, após 2 h de exposição a 45ºC. Todos os lotes mantiveram VA satisfatório até 3 dias de armazenamento de 37ºC, enquanto que, a 28 e 2-8ºC, o mesmo ocorreu com 10 e 360 dias, respectivamente. À temperatura ideal de armazenamento (2-8ºC), 100% dos lotes retiveram a potência mínima por período de tempo mais longo (16 meses) do que o prazo de validade (12 meses), o que permite sugerir que a validade da vacina contra a Raiva, que nos países da América Latina e Caribe é de 6 a 12 meses, poderia ser ampliada para 16 meses, de modo a evitar o descarte de produto em condições de uso.
APA, Harvard, Vancouver, ISO, and other styles
7

De Berardis, Domenico, Carmine Tomasetti, Maurizio Pompili, Gianluca Serafini, Federica Vellante, Michele Fornaro, Alessandro Valchera, et al. "An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine." Current Topics in Medicinal Chemistry 20, no. 7 (April 23, 2020): 554–84. http://dx.doi.org/10.2174/1568026620666200131100316.

Full text
Abstract:
Background: A research on mood disorder pathophysiology has hypothesized abnormalities in glutamatergic neurotransmission, by suggesting further investigation on glutamatergic N-methyl-Daspartate (NMDA) receptor modulators in treating Major Depressive Disorder (MDD). Esketamine (ESK), an NMDA receptor antagonist able to modulate glutamatergic neurotransmission has been recently developed as an intranasal formulation for treatment-resistant depression (TRD) and for rapid reduction of depressive symptomatology, including suicidal ideation in MDD patients at imminent risk for suicide. Objective: The present study aims at investigating recent clinical findings on research on the role of the glutamatergic system and ESK in treating suicidal depression in MDD and TRD. Methods: A systematic review was here carried out on PubMed/Medline, Scopus and the database on U.S. N.I.H. Clinical Trials (https://clinicaltrials.gov) and the European Medical Agency (EMA) (https://clinicaltrialsregister.eu) from inception until October 2019. Results: Intravenous infusion of ESK is reported to elicit rapid-acting and sustained antidepressant activity in refractory patients with MDD and TRD. In phase II studies, intranasal ESK demonstrated a rapid onset and a persistent efficacy in patients with TRD as well as in MDD patients at imminent risk for suicide. However, some data discrepancies have emerged in phase III studies. Conclusion: The U.S. Food and Drug Administration (FDA) granted fast track and Breakthrough Therapy Designation to Janssen Pharmaceuticals®, Inc. for intranasal ESK in 2013 for treatment-resistant depression (TRD) and in 2016 for the treatment of MDD with an imminent risk of suicide. However, further studies should be implemented to investigate the long-term efficacy and safety of intranasal ESK.
APA, Harvard, Vancouver, ISO, and other styles
8

Heckelman, R. G. "N.I.M. Revisited." Academic Therapy 21, no. 4 (March 1986): 411–20. http://dx.doi.org/10.1177/105345128602100403.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dent, N. J. H. "I–N.J.H. Dent." Aristotelian Society Supplementary Volume 72, no. 1 (June 1, 1998): 57–73. http://dx.doi.org/10.1111/1467-8349.00034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lupin, Alan J., and Noboru Yamanaka. "THE N.I.F. CLASSIFICATION OF OSSICULAR DISORDERS." Otology & Neurotology 10, no. 6 (November 1989): 481–84. http://dx.doi.org/10.1097/00129492-198911000-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "N.I.H"

1

Suroso Abu Hudzaifah Abdul Salam. N.I.I. dalam timbangan aqidah. Jakarta: Pustaka al-Kautsar, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Workshop on N.I.R. Research Award Schemes: a Strategy for Developing National Research Capacity (1992 Tlokweng, Botswana). Proceedings of a Workshop on N.I.R. Research Award Schemes: A Strategy for Developing National Research Capacity, 3rd-7th August, 1992. Gaborone: National Institute of Development Research and Documentation, University of Botswana, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Harden, Victoria. Inventing the N.I.H.: Federal Biomedical Research Policy, 1887-1937. The Johns Hopkins University Press, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Publishing, Standard. 2005-06 Standard Lesson Commentary N.i.v. (Standard Lesson Commentary). Standard Publishing Company, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ltd, ICON Group. N.I.C. CORP. (NIHON IRYO JIMU CENTER): International Competitive Benchmarks and Financial Gap Analysis. 2nd ed. Icon Group International, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

How The Nih Can Help You Get Funded An Insiders Guide To Grant Strategy. Oxford University Press Inc, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Autonomy and well-being in the aging population - Concepts and design of the Logitudinal Aging Study - Amsterdam (N.I.G. Trend Studies). Netherlands Institute of Gerontology, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "N.I.H"

1

Vincent-Falquet, J. C., R. Callard, M. Souvras, C. Xueref, N. Gibelin, and L. Peyron. "In Vitro Determination of Antigenic Potency of Rabies Vaccine and Comparison with N.I.H. Test." In Rabies in the Tropics, 312–17. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70060-6_41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Băldean, Doru-Laurean. "Comparative Analysis of Three Distinct Porsche Models Concerning N.V.H. Aspects." In The 30th SIAR International Congress of Automotive and Transport Engineering, 209–13. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-32564-0_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Berchez, Jean-Pierre, and Timothy Ströbele. "Bankenspezifische Software Entwicklung: Erfolgreiche Projektkontrolle bei N.C.H. Spa mit Miro.BAS." In Impulse aus der Wirtschaftsinformatik, 151–65. Heidelberg: Physica-Verlag HD, 2004. http://dx.doi.org/10.1007/978-3-7908-2683-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Elden, M. "Innovation can be Learned — Some Issues in Designing a Large Scale Norwegian Innovation Program (N.I.P)." In Creativity and Innovation: towards a European Network, 75–78. Dordrecht: Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-009-2827-5_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Babu, Y. Sudhakar, Charles E. Bugg, and William J. Cook. "CRYSTAL STRUCTURE OF CALMODULIN11Research supported by N.I.H. grants GM-29427, CA-13148 and DE-02670." In Calcium-Binding Proteins in Health and Disease, 305–11. Elsevier, 1987. http://dx.doi.org/10.1016/b978-0-12-521040-9.50056-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"Government services, n.i.e." In International trade statistics yearbook 2013, Volume II: trade by commodity, 436. UN, 2014. http://dx.doi.org/10.18356/ccb8a584-en.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Creutz, C. E., W. J. Zaks, H. C. Hamman, W. H. Martin, D. S. Drust, and S. J. Parsons. "CHARACTERIZATION OF CALCIUM-DEPENDENT CHROMAFFIN GRANULE-BINDING PROTEINS11Supported by grants from the N.I.H. (DK33151 and CA 40042), the N.S.F. (PCM8206453) and the Council for Tobacco Research (1560)." In Calcium-Binding Proteins in Health and Disease, 606–8. Elsevier, 1987. http://dx.doi.org/10.1016/b978-0-12-521040-9.50112-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nowak, Thomas. "Manganese and Phosphoenolpyruvate Carboxykinase11The work discussed in this article which was performed in the author's laboratory has been generously supported by N.I.H. grants AM 17049 and AM 00486." In Manganese in Metabolism and Enzyme Function, 165–91. Elsevier, 1986. http://dx.doi.org/10.1016/b978-0-12-629050-9.50015-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

"Government services, n.i.e. (EBOPS code 291)." In International Trade Statistics Yearbook (Ser. G), 298. UN, 2019. http://dx.doi.org/10.18356/fb09bec3-en.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"Government services, n.i.e. (EBOPS code 291)." In International Trade Statistics Yearbook (Ser. G), 296–97. UN, 2020. http://dx.doi.org/10.18356/f351b7d6-en.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "N.I.H"

1

Sinha, A. K., S. K. Samantaray, Chiranjib Bhattacharjee, Avinash R. Jha, Randeep Das, and Tarun S. Tomar. "Cost Benefit Analysis of solar powered LED based lighting system for N.I.T. Silchar." In 2009 International Conference on Power Systems. IEEE, 2009. http://dx.doi.org/10.1109/icpws.2009.5442765.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'N.I.H' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography